Case Report: Donor-derived early T-cell precursor acute lymphoblastic leukemia following an allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Case Study: Early T-cell Precursor Acute Lymphoblastic Leukemia Arising from Donor Cells After Allogeneic Hematopoietic Stem Cell Transplantation in a Child with Severe Aplastic Anemia

  • By

  • Zhi Chen

  • Ming Sun

  • Zhuo Wang

  • Li Yang

  • Yu Du

  • Fang Tao

  • Wei Wang

  • Lan-Nan Zhang

  • Hao Xiong

  • September 10, 2026

Share

Objective:

To report a case of umbilical cord blood-derived early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in a child with severe aplastic anemia.

Approach:
  • Case Report: A 7-year-old girl with severe aplastic anemia underwent allo-HSCT using umbilical cord blood and developed ETP-ALL 2 years and 5 months post-transplant.
Key Findings:
  • The patient developed ETP-ALL from umbilical cord blood donor cells after allo-HSCT.
  • Despite multiple chemotherapy regimens, the patient did not achieve remission and ultimately died from the disease.
  • The case illustrates the refractory nature of donor cell leukemia and indicates the need for further investigation into its biological mechanisms.
Interpretation:

The outcome illustrates the challenges in treating donor cell leukemia arising from umbilical cord blood, emphasizing the need for better understanding of its biological mechanisms.

Limitations:
  • The rarity of donor cell leukemia limits the ability to generalize findings.
  • The case study does not provide extensive data on the molecular mechanisms involved.
Conclusion:

The case underscores the serious implications of donor cell leukemia in pediatric patients post-transplant and the necessity for ongoing research.

Original Source(s)

Related Content